Skip to main content
Journal cover image

Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.

Publication ,  Journal Article
Lang, NN; Ahmad, FA; Cleland, JG; O'Connor, CM; Teerlink, JR; Voors, AA; Taubel, J; Hodes, AR; Anwar, M; Karra, R; Sakata, Y; Ishihara, S ...
Published in: Eur J Heart Fail
July 2021

AIMS: Nitroxyl provokes vasodilatation and inotropic and lusitropic effects in animals via post-translational modification of thiols. We aimed to compare effects of the nitroxyl donor cimlanod (BMS-986231) with those of nitroglycerin (NTG) or placebo on cardiac function in patients with chronic heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: In a randomized, multicentre, double-blind, crossover trial, 45 patients with stable HFrEF were given a 5 h intravenous infusion of cimlanod, NTG, or placebo on separate days. Echocardiograms were done at the start and end of each infusion period and read in a core laboratory. The primary endpoint was stroke volume index derived from the left ventricular outflow tract at the end of each infusion period. Stroke volume index with placebo was 30 ± 7 mL/m2 and was lower with cimlanod (29 ± 9 mL/m2 ; P = 0.03) and NTG (28 ± 8 mL/m2 ; P = 0.02). Transmitral E-wave Doppler velocity on cimlanod or NTG was lower than on placebo and, consequently, E/e' (P = 0.006) and E/A ratio (P = 0.003) were also lower. NTG had similar effects to cimlanod on these measurements. Blood pressure reduction was similar with cimlanod and NTG and greater than with placebo. CONCLUSION: In patients with chronic HFrEF, the haemodynamic effects of cimlanod and NTG are similar. The effects of cimlanod may be explained by venodilatation and preload reduction without additional inotropic or lusitropic effects. Ongoing trials of cimlanod will further define its potential role in the treatment of heart failure.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Heart Fail

DOI

EISSN

1879-0844

Publication Date

July 2021

Volume

23

Issue

7

Start / End Page

1147 / 1155

Location

England

Related Subject Headings

  • Stroke Volume
  • Nitrogen Oxides
  • Humans
  • Hemodynamics
  • Heart Failure
  • Double-Blind Method
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lang, N. N., Ahmad, F. A., Cleland, J. G., O’Connor, C. M., Teerlink, J. R., Voors, A. A., … McMurray, J. J. V. (2021). Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. Eur J Heart Fail, 23(7), 1147–1155. https://doi.org/10.1002/ejhf.2138
Lang, Ninian N., Faheem A. Ahmad, John G. Cleland, Christopher M. O’Connor, John R. Teerlink, Adriaan A. Voors, Jorg Taubel, et al. “Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.Eur J Heart Fail 23, no. 7 (July 2021): 1147–55. https://doi.org/10.1002/ejhf.2138.
Lang NN, Ahmad FA, Cleland JG, O’Connor CM, Teerlink JR, Voors AA, et al. Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. Eur J Heart Fail. 2021 Jul;23(7):1147–55.
Lang, Ninian N., et al. “Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.Eur J Heart Fail, vol. 23, no. 7, July 2021, pp. 1147–55. Pubmed, doi:10.1002/ejhf.2138.
Lang NN, Ahmad FA, Cleland JG, O’Connor CM, Teerlink JR, Voors AA, Taubel J, Hodes AR, Anwar M, Karra R, Sakata Y, Ishihara S, Senior R, Khemka A, Prasad NG, DeSouza MM, Seiffert D, Ye JY, Kessler PD, Borentain M, Solomon SD, Felker GM, McMurray JJV. Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. Eur J Heart Fail. 2021 Jul;23(7):1147–1155.
Journal cover image

Published In

Eur J Heart Fail

DOI

EISSN

1879-0844

Publication Date

July 2021

Volume

23

Issue

7

Start / End Page

1147 / 1155

Location

England

Related Subject Headings

  • Stroke Volume
  • Nitrogen Oxides
  • Humans
  • Hemodynamics
  • Heart Failure
  • Double-Blind Method
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology